SLC6A14-mediated carnitine transmembrane uptake from PPARγ⁺ cancer-associated fibroblasts promotes recurrence of pancreatic cancer

This study investigates the role of the SLC6A14 gene in the recurrence of pancreatic cancer (PC), particularly focusing on how carnitine uptake from PPARγ⁺ cancer-associated fibroblasts (CAFs) influences tumor growth. The authors found that elevated carnitine levels in tumor cells promote early recurrence through enhanced fatty acid β-oxidation, and they suggest that targeting the carnitine shuttle system in combination with existing therapies could be an effective strategy to reduce recurrence rates in PC.